We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
MYLOTARG@ is a CD33-directed antibody-drug conjugate indicated for treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults treatment of relapsed or refractory CD33-positive AML in adults and in pediatric patients 2 years and older
The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.
Trade Partners
Franchise
Download PDF
+91-9953494942